David Jentsch: Impulsivity, Addiction, and Diversity in Neuroscience

Added:

Paper Retrospective
Neural Pathways
Impulsivity's Role
Individual Variation
Model Diversity
Strain Differences
Relevance to Humans
Embracing Diversity

Paper Retrospective

0:01
Playing Section
  • 1

    The 1999 paper on frontal lobe dysfunction in addiction was a joy to write with a mentor and friend.

  • 2

    Introducing a novel idea about inhibitory control loss was risky but has been strongly supported by evidence over the years.

  • 3

    Despite its success, many questions remain about the underlying neural mechanisms and causal interventions.

Basic concepts of neurotransmission, specifically the function of dopamine as a key neurotransmitter in reward and motor pathways.
An understanding of G-protein coupled receptors (GPCRs), with a specific focus on the inhibitory nature and signaling pathways of D2 dopamine receptors.
The fundamental neurobiology of addiction, including the mesolimbic pathway (ventral tegmental area to nucleus accumbens) and how substances alter reward processing.
An introductory understanding of behavioral genetics, specifically how genetic variation contributes to individual differences in behavior and cognitive traits.
The purpose and methodological limitations of using traditional, inbred animal models in translational neuroscience and psychiatric research.
Advanced psychopharmacology, exploring how novel therapeutic agents target D2 and D3 dopamine receptors to treat impulsive-compulsive disorders.
The use of genetically diverse mouse populations (such as Collaborative Cross or Diversity Outbred) to better replicate human genetic heterogeneity in preclinical trials.
Translational neuroimaging techniques, such as Positron Emission Tomography (PET), to measure receptor availability and density in living human subjects with substance use disorders.
The application of precision psychiatry, using genetic and neurobehavioral biomarkers (like high-impulsivity phenotypes) to tailor addiction treatments.
Neuroethical and societal implications surrounding genetic screening for addiction vulnerability and the classification of behavioral traits as biomarkers.
217 views2likes37:27@stephenvmahler56Original Release: 2022-10-30

Addiction involves dysfunction in frontal cortical circuits that regulate inhibitory control over reward-seeking behaviors, with individual differences in baseline dopamine D2 receptor density strongly predicting susceptibility to substance use disorders; this relationship is evolutionarily conserved across species from mice to humans, highlighting the importance of using genetically diverse animal models to understand addiction mechanisms.